Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 15809305)

1.

Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site.

Ali SM, Sabatini DM.

J Biol Chem. 2005 May 20;280(20):19445-8. Epub 2005 Apr 4.

2.

Identification of a conserved motif required for mTOR signaling.

Schalm SS, Blenis J.

Curr Biol. 2002 Apr 16;12(8):632-9.

3.

Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site.

Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis PB, Thomas G.

J Biol Chem. 2002 May 31;277(22):20104-12. Epub 2002 Mar 25.

4.

TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.

Schalm SS, Fingar DC, Sabatini DM, Blenis J.

Curr Biol. 2003 May 13;13(10):797-806.

5.

Characterization of phosphatidylinositol 3-kinase-dependent phosphorylation of the hydrophobic motif site Thr(389) in p70 S6 kinase 1.

Romanelli A, Dreisbach VC, Blenis J.

J Biol Chem. 2002 Oct 25;277(43):40281-9. Epub 2002 Aug 14.

6.

Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase.

Holz MK, Blenis J.

J Biol Chem. 2005 Jul 15;280(28):26089-93. Epub 2005 May 19.

7.
8.

Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.

Park IH, Bachmann R, Shirazi H, Chen J.

J Biol Chem. 2002 Aug 30;277(35):31423-9. Epub 2002 Jun 26.

9.

Kinase activities associated with mTOR.

Yonezawa K, Yoshino KI, Tokunaga C, Hara K.

Curr Top Microbiol Immunol. 2004;279:271-82. Review.

PMID:
14560963
10.

Rictor is a novel target of p70 S6 kinase-1.

Treins C, Warne PH, Magnuson MA, Pende M, Downward J.

Oncogene. 2010 Feb 18;29(7):1003-16. doi: 10.1038/onc.2009.401. Epub 2009 Nov 23.

PMID:
19935711
11.

Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.

Liu L, Li F, Cardelli JA, Martin KA, Blenis J, Huang S.

Oncogene. 2006 Nov 9;25(53):7029-40. Epub 2006 May 22.

PMID:
16715128
12.

Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase.

Chrestensen CA, Sturgill TW.

J Biol Chem. 2002 Aug 2;277(31):27733-41. Epub 2002 May 16.

13.
14.

Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro.

Isotani S, Hara K, Tokunaga C, Inoue H, Avruch J, Yonezawa K.

J Biol Chem. 1999 Nov 26;274(48):34493-8.

15.

The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin.

McMahon LP, Choi KM, Lin TA, Abraham RT, Lawrence JC Jr.

Mol Cell Biol. 2002 Nov;22(21):7428-38.

16.

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM.

Curr Biol. 2004 Jul 27;14(14):1296-302.

17.

Characterization of S6K2, a novel kinase homologous to S6K1.

Lee-Fruman KK, Kuo CJ, Lippincott J, Terada N, Blenis J.

Oncogene. 1999 Sep 9;18(36):5108-14.

18.

hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.

Byfield MP, Murray JT, Backer JM.

J Biol Chem. 2005 Sep 23;280(38):33076-82. Epub 2005 Jul 27.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk